查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826986

2025年呼吸道融合細胞病毒（RSV）診斷全球市場報告

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，呼吸道融合細胞病毒(RSV) 診斷市場快速擴張，市場規模從 2024 年的 10.1 億美元成長至 2025 年的 11.2 億美元，複合年成長率為 10.7%。預測期內的成長歸因於照護現場診斷的普及、政府改進 RSV 診斷的舉措、兒童呼吸道疾病患病率的上升、醫院內感染數量的增加以及對非侵入性診斷方法的需求不斷成長。

呼吸道融合細胞病毒(RSV) 診斷市場預計將在未來幾年內快速成長，到 2029 年將達到 16.7 億美元，複合年成長率為 10.5%。預測期內成長的主要促進因素包括：RSV感染疾病的上升、RSV 診斷意識的增強、醫療保健基礎設施的擴張、全球醫療保健支出的增加以及老年人口的成長。預測期內的主要趨勢包括：呼吸道融合細胞病毒診斷技術的進步、診斷設備的技術進步、快速診斷檢測 (RDT) 的普及、企業診斷檢測產品組合的擴展以及基因和蛋白質組學診斷技術的進步。

呼吸道融合細胞病毒(RSV) 診斷包括檢測患者呼吸道合胞病毒 (RSV) 的檢測和方法，通常使用呼吸道樣本，例如鼻拭子或咽拭子。這些診斷對於識別導致嬰兒、幼兒和老年人呼吸道疾病的 RSV 感染至關重要，也有助於制定適當的治療和疾病管理方案。

RSV 診斷產品的主要類型包括套件和檢測試劑、儀器、試劑等。套件和檢測試劑是預先包裝好的套裝，包含試劑、材料和用於進行特定診斷測試的說明書。 RSV 檢測技術多種多樣，包括分子診斷、免疫檢測和快速抗原檢測。樣本類型包括鼻拭子、咽拭子和支氣管肺泡灌洗液。這些診斷方法可用於醫院、診斷實驗室、居家照護機構和其他醫療保健機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供呼吸道融合細胞病毒(RSV) 診斷市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的呼吸道融合細胞病毒病毒 (RSV) 診斷市場佔有率、詳細的呼吸道融合細胞病毒呼吸道融合細胞病毒(RSV) 診斷市場、市場趨勢和機遇，以及您在呼吸道融合細胞病毒(RSV) 行業取得成功所需的數量。本呼吸道融合細胞病毒(RSV) 診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年10.5%的成長預測較先前的預測略有下降0.1%。這一下降主要歸因於美國與其他國家之間關稅的影響。貿易摩擦可能導致法國和韓國開發的快速呼吸道合胞病毒抗原檢測套組和聚合酵素鏈鎖反應試劑價格上漲，從而導致診斷延誤和兒科傳染病檢查成本上升，並擾亂美國的小兒科醫療服務。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

呼吸系統疾病的日益普及預計將推動對呼吸道融合細胞病毒(RSV) 診斷的需求。由於空氣污染、吸菸、氣候變遷、都市化和慢性病盛行率上升等因素，氣喘、慢性阻塞性肺病(COPD)、肺炎和呼吸道感染疾病等呼吸道疾病變得越來越普遍。 RSV 診斷在準確及時地識別感染，實現適當的治療、管理和預防嚴重併發症發揮著至關重要的作用。例如，2024 年 11 月，澳洲健康與福利研究所報告稱，預計 2022 年澳洲將有 280 萬人（佔總人口的 11%）患有氣喘。 2023 年，氣喘將佔總疾病負擔的 2.5% 和所有呼吸系統疾病負擔的 35%，2022 年將有 467 人死於氣喘。因此，呼吸系統疾病的日益流行正在推動 RSV 診斷市場的成長。

呼吸道合胞病毒 (RSV) 診斷市場的主要企業正專注於創新的多病毒診斷測試，以提高效率和準確性。多病毒診斷測試能夠從單一患者樣本同時檢測多種呼吸道病毒，例如呼吸道合胞病毒 (RSV)、流感病毒和新冠肺炎 (COVID-19)。例如，2023 年 1 月，美國臨床檢測公司 Sonora Quest Laboratories 推出了一種新的分子診斷測試，可從單一檢體中檢測新冠肺炎、RSV 和流感病毒。結合這些測試簡化了流程，減少了對多個樣本的需求，並實現了更快、更全面的診斷。這種方法使醫療保健提供者能夠快速做出治療決策並防止這些病毒的傳播。

2023年11月，芬蘭生技公司Medix Biochemica收購了ViroStat LLC，收購金額未揭露。此次收購整合了ViroStat在呼吸道合胞病毒（RSV）檢測單株抗體和抗原檢測套件的專業知識，擴大了Medix Biochemica的感染疾病診斷產品組合。總部位於美國的ViroStat LLC專注於開發包括RSV在內的多種感染疾病的診斷解決方案，進一步鞏固了Medix Biochemica在RSV診斷市場的地位。

呼吸道融合細胞病毒(RSV) 診斷市場由提供診斷諮詢、研發援助、訓練和技術支援等服務的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。呼吸道融合細胞病毒(RSV) 診斷市場還包括螢光檢測套組、多重檢測板、樣本採集設備和自動化檢測設備的銷售。該市場中的產品價值是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球呼吸道融合細胞病毒(RSV) 診斷：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球呼吸道融合細胞病毒（RSV）診斷市場：成長率分析
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場表現：規模與成長，2019-2024 年
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球呼吸道融合細胞病毒(RSV) 診斷：總目標市場 (TAM)

第6章 市場細分

  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依產品類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 套件和檢測試劑
  • 裝置
  • 試劑
  • 其他
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 免疫檢測
  • 快速抗原檢測
  • 其他
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依樣本類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 鼻拭子
  • 咽拭子
  • 支氣管肺泡灌洗
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷實驗室
  • 居家照護
  • 其他
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：套件和檢測試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 快速抗原檢測套件
  • 基於PCR的檢測
  • 血清學檢測
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：設備細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR分析儀
  • 免疫檢測分析儀
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：試劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR試劑
  • 抗體試劑
  • 酵素試劑
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 採樣裝置
  • 傳輸介質

第7章 區域和國家分析

  • 全球呼吸道融合細胞病毒(RSV) 診斷市場各地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球呼吸道融合細胞病毒(RSV) 診斷市場（依國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 呼吸道融合細胞病毒（RSV）診斷市場：競爭格局
  • 呼吸道融合細胞病毒（RSV）診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Merck KGaA

第31章：其他領先和創新企業

  • Becton, Dickinson, and Company
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • BIOMERIEUX SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Acon Laboratories Inc.
  • Cepheid Inc.
  • Meridian Bioscience Inc.
  • Seegene Inc.
  • LumiraDx Ltd.
  • Sekisui Diagnostics Ltd.
  • Boditech Med Inc.
  • Trinity BIoTech plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年呼吸道融合細胞病毒（RSV）診斷市場：提供新機會的國家
  • 2029年呼吸道融合細胞病毒（RSV）診斷市場：細分市場帶來新機會
  • 呼吸道融合細胞病毒(RSV) 診斷市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34139u

Respiratory syncytial virus (RSV) diagnostics encompass the tests and methods used to detect RSV in patients, typically through respiratory samples such as nasal or throat swabs. These diagnostics are essential for identifying RSV infections, which can cause respiratory illnesses in infants, young children, and the elderly, aiding in appropriate treatment and disease management.

The primary types of RSV diagnostic products include kits and assays, instruments, reagents, and others. Kits and assays are pre-packaged sets containing reagents, materials, and instructions for conducting specific diagnostic tests. Various technologies are used for RSV detection, including molecular diagnostics, immunoassays, and rapid antigen detection tests. Sample types include nasal swabs, throat swabs, and bronchoalveolar lavage. These diagnostics are utilized in hospitals, diagnostic laboratories, home care settings, and other healthcare environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The respiratory syncytial virus (RSV) diagnostics market research report is one of a series of new reports from The Business Research Company that provides respiratory syncytial virus (RSV) diagnostics market statistics, including respiratory syncytial virus (RSV) diagnostics industry global market size, regional shares, competitors with a respiratory syncytial virus (RSV) diagnostics market share, detailed respiratory syncytial virus (RSV) diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory syncytial virus (RSV) diagnostics industry. This respiratory syncytial virus (RSV) diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory syncytial virus (rsv) diagnostics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising adoption of point-of-care diagnostics, government initiatives to improve RSV diagnostics, rising incidence of respiratory diseases in children, growth in hospital-acquired infections, and rising demand for non-invasive diagnostic methods.

The respiratory syncytial virus (rsv) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory syncytial virus (RSV) infections, rising awareness about RSV diagnostics, expanding healthcare infrastructure, increasing healthcare spending globally, and growth in the elderly population. Major trends in the forecast period include advances in molecular diagnostic technologies, technological advancements in diagnostic devices, adoption of rapid diagnostic tests (RDTs), expansion of diagnostic test portfolios by companies, and advances in genetic and proteomic diagnostics.

The forecast of 10.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pediatric practices by inflating prices of rapid RSV antigen test kits and Polymerase Chain Reaction reagents developed in France and South Korea, resulting in delayed diagnosis and higher pediatric infectious disease testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of respiratory diseases is expected to drive the demand for respiratory syncytial virus (RSV) diagnostics. Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections, are becoming more widespread due to factors such as air pollution, smoking, climate change, urbanization, and the rising incidence of chronic conditions. RSV diagnostics play a crucial role in identifying infections accurately and in a timely manner, enabling appropriate treatment, management, and prevention of severe complications, particularly in vulnerable populations. For instance, in November 2024, the Australian Institute of Health and Welfare reported that an estimated 2.8 million people (11% of the population) in Australia were living with asthma in 2022. Asthma accounted for 2.5% of the total disease burden and 35% of the burden from all respiratory conditions in 2023, with 467 asthma-related deaths in 2022. Therefore, the rising prevalence of respiratory diseases is fueling growth in the RSV diagnostics market.

Leading companies in the RSV diagnostics market are focusing on innovative multi-virus diagnostic testing to enhance efficiency and accuracy. Multi-virus diagnostic testing enables the simultaneous detection of multiple respiratory viruses, such as RSV, influenza, and COVID-19, from a single patient sample. For example, in January 2023, Sonora Quest Laboratories, a US-based clinical laboratory testing company, introduced a new molecular diagnostic test that detects COVID-19, RSV, and influenza using a single sample. By combining these tests, the process is streamlined, reducing the need for multiple samples and enabling faster, more comprehensive diagnoses. This approach allows healthcare providers to make quicker treatment decisions and helps prevent the spread of these viruses.

In November 2023, Medix Biochemica, a Finland-based biotechnology company, acquired ViroStat LLC for an undisclosed amount. This acquisition expands Medix Biochemica's infectious disease diagnostic portfolio by integrating ViroStat's expertise in monoclonal antibodies and antigen detection kits for RSV testing. ViroStat LLC, a US-based company, specializes in developing diagnostic solutions for various infectious diseases, including RSV, further strengthening Medix Biochemica's position in the RSV diagnostics market.

Major players in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMERIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.

North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory syncytial virus (RSV) diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Respiratory Syncytial Virus (RSV) Diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory syncytial virus (RSV) diagnostics market consists of revenues earned by entities by providing services such as diagnostic consultation, research and development support, training and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory syncytial virus (RSV) diagnostics market also includes sales of immunofluorescence test kits, multiplex panels, sample collection devices and automated testing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory syncytial virus (rsv) diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory syncytial virus (rsv) diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory syncytial virus (rsv) diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kits And Assays; Instruments; Reagents; Other Product Types
  • 2) By Technology: Molecular Diagnostics; Immunoassays; Rapid Antigen Detection Tests; Other Technologies
  • 3) By Sample Type: Nasal Swabs; Throat Swabs; Bronchoalveolar Lavage
  • 4) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Kits And Assays: Rapid Antigen Detection Kits; PCR-based Assays; Serological Assays
  • 2) By Instruments: PCR Analyzers; Immunoassay Analyzers
  • 3) By Reagents: PCR Reagents; Antibody Reagents; Enzyme Reagents
  • 4) By Other Product Types: Sample Collection Devices; Transport Media
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Merck KGaA; Becton, Dickinson, and Company; Quest Diagnostics Incorporated; Hologic Inc.; BIOMERIEUX SA; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Acon Laboratories Inc.; Cepheid Inc.; Meridian Bioscience Inc.; Seegene Inc.; LumiraDx Ltd.; Sekisui Diagnostics Ltd.; Boditech Med Inc.; Trinity Biotech plc; R-Biopharm AG; GeneTex Inc.; Creative Diagnostics; Certest Biotec S.L.; Clarity Diagnostics LLC; Genes 2Me LLP; Coris BioConcept S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Syncytial Virus (RSV) Diagnostics Market Characteristics

3. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends And Strategies

4. Respiratory Syncytial Virus (RSV) Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Syncytial Virus (RSV) Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Rate Analysis
  • 5.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Total Addressable Market (TAM)

6. Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation

  • 6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Assays
  • Instruments
  • Reagents
  • Other Product Types
  • 6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassays
  • Rapid Antigen Detection Tests
  • Other Technologies
  • 6.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Swabs
  • Throat Swabs
  • Bronchoalveolar Lavage
  • 6.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Kits And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Antigen Detection Kits
  • PCR-based Assays
  • Serological Assays
  • 6.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Analyzers
  • Immunoassay Analyzers
  • 6.7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • Antibody Reagents
  • Enzyme Reagents
  • 6.8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Collection Devices
  • Transport Media

7. Respiratory Syncytial Virus (RSV) Diagnostics Market Regional And Country Analysis

  • 7.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 8.1. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 9.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 9.2. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 10.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 11.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 11.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 12.1. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 13.1. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 14.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 14.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 15.1. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 15.2. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 16.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 17.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 18.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 19.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 20.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 21.1. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 21.2. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 22.1. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 23.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 23.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 24.1. USA Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 24.2. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 25.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 25.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 26.1. South America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 26.2. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 27.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 28.1. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 28.2. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 29.1. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 29.2. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape
  • 30.2. Respiratory Syncytial Virus (RSV) Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Syncytial Virus (RSV) Diagnostics Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson, and Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Hologic Inc.
  • 31.4. BIOMERIEUX SA
  • 31.5. QuidelOrtho Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Acon Laboratories Inc.
  • 31.9. Cepheid Inc.
  • 31.10. Meridian Bioscience Inc.
  • 31.11. Seegene Inc.
  • 31.12. LumiraDx Ltd.
  • 31.13. Sekisui Diagnostics Ltd.
  • 31.14. Boditech Med Inc.
  • 31.15. Trinity Biotech plc

32. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Syncytial Virus (RSV) Diagnostics Market

34. Recent Developments In The Respiratory Syncytial Virus (RSV) Diagnostics Market

35. Respiratory Syncytial Virus (RSV) Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer